Menstrual irregularities and related plasma hormone levels in multiple sclerosis patients treated with beta interferone

Acta Medica Iranica

Volumn 48, Issue 1, 2010, Pages 36-41

  Nabavi, Seyed Massood ^a   Koupai, Shideh Abedi ^a   Nejati, Mohammad Reza ^b   Garshasbi, Ehya ^a   Jalali, Mohammad Reza ^a  

^a SHAHED UNIVERSITY   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hormones; Menstruation disturbances; Multiple sclerosis; Progesterone

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; FOLLITROPIN; INTERFERON BETA SERINE; LIOTHYRONINE; LUTEINIZING HORMONE; PROLACTIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERMENORRHEA; HYPERPROLACTINEMIA; LIOTHYRONINE BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENSTRUAL IRREGULARITY; MENSTRUATION; MULTIPLE SCLEROSIS; OLIGOMENORRHEA; POLYMENORRHEA; PROLACTIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MENSTRUATION DISTURBANCES; MULTIPLE SCLEROSIS; PITUITARY HORMONES, ANTERIOR;

EID: 77649221325     PISSN: 00446025     EISSN: 00446025     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. th ed. New York: McGraw-Hill; 2005. p. 902-28.
2. th ed. Baltimore: Williams and Wilkins; 1995. p. 773-92.
3. Zych-Twardowska E, Wajgt A. Serum prolactin and sex hormone concentrations in patients with multiple sclerosis. Med Sci Monit 1999;5(2):216-20.
4. Zych-Twardowska E, Wajgt A. Blood levels of selected hormones in patients with multiple sclerosis. Med Sci Monit 2001;7(5):1005-12.
5. Cavalla P, Rovei V, Masera S, Vercellino M, Massobrio M, Mutani R, et al. Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol Sci 2006;27(4):231-9.
6. Grinsted L, Heltberg A, Hagen C, Djursing H. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med 1989;226(4):241-4.
7. Miyamoto T, Miyamoto M, Yokota N, Kubo J, Hirata K. A case of multiple sclerosis with hypothalamic amenorrhea. Rinsho Shinkeigaku 2000;40(3):263-7.
8. Tanaka M, Suzuki T, Endo K, Harayama H. A case of multiple sclerosis with galactorrhea-amenorrhea syndrome. Rinsho Shinkeigaku 1997;37(6):483-6.
9. Davies JS, Hinds NP, Scanlon MF. Growth hormone deficiency and hypogonadism in a patient with multiple sclerosis. Clin Endocrinol (Oxf) 1996;44(1):117-9.
10. Kira J, Harada M, Yamaguchi Y, Shida N, Goto I. Hyperprolactinemia in multiple sclerosis. J Neurol Sci 1991;102(1):61-6.
11. Heesen C, Gold SM, Huitinga I, Reul JM. Stress and hypothalamic- pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis: a review. Psychoneuroendocrinology 2007;32(6):604-18.
12. Tonacchera M, Ferrarini E, Dimida A, Agretti P, De Marco G, De Servi M, et al. Gonadotrophin receptor blocking antibodies measured by the use of cell lines stably expressing human gonadotrophin receptors are not detectable in women with 46,XX premature ovarian failure. Clin Endocrinol (Oxf) 2004;61(3):376-81.
13. Hansen BL, Hansen GN, Hagen C, Brodersen P. Autoantibodies against pituitary peptides in sera from patients with multiple sclerosis. J Neuroimmunol 1983;5(2):171-83.
14. Moller A, Hansen BL, Hansen GN, Hagen C. Autoantibodies in sera from patients with multiple sclerosis directed against antigenic determinants in pituitary growth hormoneproducing cells and in structures containing vasopressin/ oxytocin. J Neuroimmunol 1985;8(2-3):177-84.
15. Linssen WH, Notermans NC, Hommes OR, Rolland R. Amenorrhea after immunosuppressive treatment of multiple sclerosis. Acta Neurol Scand 1987;76(3):204-9.
16. Pakulski LA, DiMarco LM. Severe vaginal bleeding associated with recombinant interferon beta-1B. Ann Pharmacother 1997;31(1):50-2.
17. Then Bergh F, Kümpfel T, Yassouridis A, Lechner C, Holsboer F, Trenkwalder C. Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis. Clin Endocrinol (Oxf) 2007;66(2):295-303.
18. Heesen C, Schulz H, Schmidt M, Gold S, Tessmer W, Schulz KH. Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav Immun 2002;16(3):282-7.
19. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50(1):121-7.
20. Falaschi P, Martocchia A, Proietti A, D'Urso R, Antonini G. High incidence of hyperandrogenism-related clinical signs in patients with multiple sclerosis. Neuro Endocrinol Lett 2001;22(4):248-50.
21. Golovkin VI, Mikhaǐlenko AA, Rakov AL. Pathogenetic role of prolactinemia in multiple sclerosis. Sov Med 1991;(10):15-7.
22. Klapps P, Seyfert S, Fischer T, Scherbaum WA. Endocrine function in multiple sclerosis. Acta Neurol Scand 1992;85(5):353-7.
23. Wei T, Lightman SL. The neuroendocrine axis in patients with multiple sclerosis. Brain 1997;120(Pt 6):1067-76.